Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wenyang Jiebiao Regimen (MAFU Granules) vs Cyclosporine in Idiopathic Membranous Nephropathy
ChiCTR2300067939Phase 3Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jan 2023
- Countries
- 1
01
Overview
Phase 3, randomised trial of MAFU granules in membranous glomerulonephritis (MGN) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: 24-hour urinary protein at 24 months. Started Jan 2023; status: recruiting.
02
Drugs
MAFU granules
03
Conditions
membranous glomerulonephritis (MGN)
Beyond the preview
Go deeper on ChiCTR2300067939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067939.